Clinical Trials Sponsored by iVascular S.L.U.

Total 429 results

iVascular S.L.U.

Not yet recruiting

Investigating the Safety and Clinical Performance of Eight iVascular Devices for Endovascular Intervention in Renal, Iliac or Femoral Arteries

Artery Disease

France
iVascular S.L.U.

Not yet recruiting

Safety and Effectiveness Evaluation of iCover Covered Stent for the Treatment of the Aorto-iliac Occlusive Disease (ILICO)

Peripheral Arterial Disease | Iliac Artery Disease | Angioplasty | Aorto-Iliac Atherosclerosis | Covered Stent

Belgium, Germany, France, Spain
iVascular S.L.U.

Recruiting

European All-comers' Multicentric Prospective REGISTRY on LUMINOR© Drug Eluting Balloon in the Superficial Femoral Artery and Popliteal Artery With 5 Years Follow-up. (LUMIFOLLOW)

Peripheral Arterial Disease | Angioplasty | Paclitaxel | Drug-eluting Balloon | Femoral Artery

France
iVascular S.L.U.

Not yet recruiting

Ischemic and Bleeding Outcomes After Angiolite Stent Implantation and an Abbreviated Dual Antiplatelet Therapy (ANGIODAPT)

Coronary Artery Disease
iVascular S.L.U.

Recruiting

Prospective, Multicentre Study to Evaluate the Thrombectomy System for Stroke: INEDIT, INDEEP and INTERCEPT (SEMTiC)

Acute Ischemic Stroke

Spain, Belgium, France, Germany
iVascular S.L.U.

Recruiting

Efficacy and Safety Evaluation of the Thromboaspiration Catheter System iNstroke in Patients With Acute Ischemic Stroke (ASPiC)

Acute Ischemic Stroke

Spain
iVascular S.L.U.

Completed

Luminor Registry: Registry of the Results of Angioplasty With Drug-eluting Balloon (Paclitaxel) in the Treatment of Infrainguinal Occlusive Lesions and Restenosis From Prior Endovascular Procedures in This Sector.

Peripheral Vascular Disease

Spain
Jena University Hospital
KKS Netzwerk; iVascular S.L.U.

Completed

Effectiveness of Paclitaxel-coated Luminor® Balloon Catheter Versus Uncoated Balloon Catheter in the Arteria Femoralis Superficialis (EffPac)

Peripheral Arterial Disease

Germany
iVascular S.L.U.
FCRE (Foundation for Cardiovascular Research and Education)

Recruiting

Investigating the Safety and Clinical Performance of Seven iVascular Devices for Endovascular Intervention in the Popliteal and/or Infrapopliteal Arteries (POP-BTK)

Peripheral Arterial Disease Below The Knee

Belgium
Hipra Scientific, S.L.U

Completed

A Phase II Trial to Evaluate the Safety and Immunogenicity of BIMERVAX® When Coadministered With Seasonal Influenza Vaccine (SIIV) in Adults Older Than 65 Years of Age Fully Vaccinated Against COVID-19

Influenza, Human | SARS CoV 2 Infection

Spain
Probelte Pharma S.L.U.

Completed

Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Alternaria Alternata

Rhinoconjunctivitis With or Without Allergic Asthma

Spain
Hipra Scientific, S.L.U

Completed

A Phase III Trial to Assess the Safety and Immunogenicity of a HIPRA's Candidate Booster Vaccination Against COVID-19.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain, Italy
Probelte Pharma S.L.U.

Recruiting

Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM (PROACAROS)

House Dust Mite Allergy

Spain
Hipra Scientific, S.L.U

Active, not recruiting

Safety and Immunogenicity of a Booster Vaccination With an Adapted Vaccine

SARS-CoV2 Infection

Spain
Probelte Pharma S.L.U.

Completed

Study to Assess the Safety and Effectiveness of Beltavac® Polymerized With Cat Dander

Rhinoconjunctivitis With or Without Allergic Asthma

Spain
Hipra Scientific, S.L.U

Completed

Assessing the Immunogenicity and Safety of a HIPRA's Candidate Booster Vaccination in Adults Fully Vaccinated With Adenovirus Vaccine Against COVID-19.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain
Bama GeVe, S.L.U.

Terminated

Prospective Evaluation of the QoL of Patients With PTS Who Receive Compression Therapy and Sulodexide (SQUARES)

Post-thrombotic Syndrome

Spain
ITF Research Pharma, S.L.U.

Completed

Study Evaluating the Efficacy and Safety of Three Formulations of Ultra-low Dose Estriol Vaginal Gel (0.005%, 0.002%, 0.0008% Estriol Vaginal Gel) for the Treatment of Vaginal Dryness in Postmenopausal Women With Vulvovaginal Atrophy

Vaginal Atrophy

Spain, Czechia, Hungary, Italy, Sweden
Kyowa Kirin Farmacéutica S.L.U.

Completed

Evaluation of the Quality of Life of Patients With Opioid-induced Constipation Under Treatment With Naloxegol (KYONAL)

Opioid-induced Constipation

Spain
Dermofarm, S.A.U

Completed

Efficacy and Safety of a Hyaluronic Acid-Based Vaginal Moisturizer Medical Device to Ease Symptoms of Vaginal Dryness (HYALU-LAUDE)

Vaginal Disease

Spain
S.L.A. Pharma AG

Recruiting

Effect of EPA-FFA on Polypectomy in Familial Adenomatous Polyposis

Familial Adenomatous Polyposis

Italy
Tigenix S.A.U.

Completed

Study to Assess Efficacy and Safety of Cx601, Adult Allogeneic Expanded Adipose-derived Stem Cells (eASC) for the Treatment of Complex Perianal Fistula(s) in Participants With Crohn's Disease (CD) (ADMIRE-CD-II)

Crohn's Disease

United States, Spain, United Kingdom, Italy, Germany, Canada, Belgium, Denmark, Poland, Czechia, France, Hungary, Israel, Puerto Rico, Sweden
Fagron Iberica S.A.U.

Completed

Retrospective Study of ImmunoFormulation for COVID-19

Covid19

Spain
Tigenix S.A.U.

Completed

Trial To Assess Efficacy Of A Chimeric Skin In Patients With Epidermolysys Bullosa (TCEB)

EPIDERMOLYSIS BULLOSA

Spain
Tigenix S.A.U.

Completed

Long-term Safety and Efficacy of Adipose-derived Stem Cells to Treat Complex Perianal Fistulas in Patients Participating in the FATT-1 Randomized Controlled Trial (LTE)

Complex Perianal Fistula

Spain
Tigenix S.A.U.

Completed

Cx611-0101, eASCs Intravenous Administration to Refractory Rheumatoid Arthritis Patients

Rheumatoid Arthritis Aggravated

Spain
S.L.A. Pharma AG

Completed

Chemoprevention Trial in Familial Adenomatous Polyposis (FAP) Coli Using EPA

FAP | Familial Adenomatous Polyposis Coli

United Kingdom
S.L.A. Pharma AG

Completed

Diltiazem Hydrochloride Cream for Anal Fissure

Chronic Anal Fissure

United Kingdom, Spain, Bulgaria, Germany, Lithuania, Romania
S.L.A. Pharma AG

Completed

Evaluation of Topical 10% Metronidazole Ointment for the Treatment of Active Perianal Crohn's Disease

Crohn's Disease

United Kingdom, United States
Tigenix S.A.U.

Completed

Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.

Crohn's Disease | Anal Fistula

Spain
Tigenix S.A.U.

Completed

Intralymphatic eASC Administration in Healthy Volunteers

Localized Adverse Reaction to Administration of Drug

Spain
S.L.A. Pharma AG

Withdrawn

A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence

Faecal Incontinence

United Kingdom
Tigenix S.A.U.

Completed

Randomized, Parallel Group, Placebo Control, Unicentric, Interventional Study to Assess the Effect of Expanded Human Allogeneic Adipose-derived Mesenchymal Adult Stem Cells on the Human Response to Lipopolysaccharyde in Human Volunteers (CELLULA)

Sepsis

Netherlands
S.L.A. Pharma AG

Completed

Naloxone SR Capsules in Patients With Opioid Induced Constipation

Chronic Pain | Opioid Induced Constipation

Germany, United Kingdom
S.L.A. Pharma AG

Completed

A Randomised Controlled Trial of the Use of Topical Metronidazole (10%) to Reduce Pain After Haemorrhoidectomy

Haemorrhoidectomy

United Kingdom
Hipra Scientific, S.L.U
Laboratorios Hipra, S.A.

Completed

Immunogenicity and Safety of a Booster Vaccination With a Recombinant Protein RBD Candidate Vaccine Against SARS-CoV-2 in Healthy Adults Volunteers Fully Vaccinated Followed by an Extension Period to Study a Fourth Dose Administration.

COVID-19 | SARS-CoV-2 Acute Respiratory Disease

Spain
S.L.A. Pharma AG

Recruiting

EPA-FFA to Treat Hospitalised Patients With COVID-19 (SARS-CoV-2)

SARS-CoV-2

Spain, United Kingdom
S.L.A. Pharma AG

Not yet recruiting

Metronidazole Ointment in Non-healing Pilonidal Sinus Wounds

Pilonidal Sinus

Turkey
Tigenix S.A.U.

Completed

Adipose Derived Mesenchymal Stem Cells for Induction of Remission in Perianal Fistulizing Crohn's Disease (ADMIRE-CD)

Crohn's Disease

Spain, Belgium, Netherlands, France, Israel, Italy, Austria, Germany
Tigenix S.A.U.

Completed

Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease (FATT1)

Anal Fistula

Spain, Germany, United Kingdom
Tigenix S.A.U.

Terminated

Safety and Efficacy of Adipose-Derived Stem Cells to Treat Complex Perianal Fistulas Patients With Crohn's Disease (FATT)

Crohn Disease | Complex Perianal Fistula

Spain, Netherlands, Austria
S.L.A. Pharma AG

Completed

Evaluation of the Pharmacokinetics of Metronidazole 10% Ointment Applied Peri Anally in Healthy Volunteers and Patients With Perianal Crohn's Disease

Perianal Crohns'

United Kingdom
S.L.A. Pharma AG

Completed

Effect of 2 Doses of EPA on Apoptosis and Cell Proliferation on Colon Mucosa

Adenomatous Polyps

Italy, United Kingdom
Universitat de Lleida
Pharmactive Biotech Products S.L.U

Recruiting

ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension (GARDOSE)

Hypertension

Spain
University of Alicante
Pharmactive Biotech Products S.L.U

Not yet recruiting

Effects of AffronEye®/ Crocuvis+® on Dry Eye Syndrome

Dry Eye Syndrome

Spain
University of Alicante
Pharmactive Biotech Products S.L.U

Completed

Effects of CROCUVIS+® on Computer Vision Syndrome, Sleep and Mood Disorders

Mood Disorders | Sleep Disorder | Computer Vision Syndrome

Spain
Biomendi S.A.U.
Pivotal S.L.

Terminated

A Multicenter Trial of the Efficacy and Safety of a New Formulation of Ibuprofen 800 mg Every 6 Hours in the Management of Postoperative Pain

Postoperative Pain

Spain
Lake Washington Vascular
Medtronic Vascular

Unknown

Lake Washington Vascular VenaSeal™ Post-Market Evaluation (New-WAVES)

Varicose Veins | Venous Reflux

United States
Hipra Scientific, S.L.U
Veristat, Inc.; Asphalion; VHIR

Recruiting

Open-label, Multi-centre, Non-Inferiority Study of Safety and Immunogenicity of BIMERVAX for the Prevention of COVID-19 in Adolescents From 12 Years to Less Than 18 Years of Age.

SARS CoV 2 Infection

Spain
Indizen Optical Technologies, S.L.U.
Universidad Europea de Madrid

Recruiting

Evaluation of the Efficacy in Decreasing Myopia Progression of the Proposed Ophthalmic Lens Prototypes

Myopia

Spain

3

Subscribe